Literature DB >> 21669943

Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation.

Shaoping Ji1, J Ronald Doucette, Adil J Nazarali.   

Abstract

Although Sirt2 is primarily expressed in oligodendrocytes of the central nervous system, its role in oligodendroglial lineage differentiation is not fully understood. Our findings demonstrate that the transcription factor Nkx2.2 binds to the Sirt2 promoter via histone deacetylase 1 (HDAC-1), the binding site for Nkx2.2 maps close to the start codon of the Sirt2 gene, and Nkx2.2 negatively regulates Sirt2 expression in CG4 cells, an oligodendroglial precursor cell line. HDAC-1 knock-down not only significantly attenuates the binding capacity of Nkx2.2 to the Sirt2 promoter but also releases repression of Sirt2 expression by Nkx2.2. Nkx2.2 over-expression down-regulates Sirt2 expression and delays differentiation of CG4 cells; in contrast, up-regulation of Sirt2 does not impact Nkx2.2 expression level. Sirt2 knock-down via RNAi or inhibition of Sirt2 by sirtinol, a Sirt2 activity inhibitor, blocks CG4 cell differentiation. Over-expression of Sirt2 facilitates CG4 cell differentiation at both molecular and cellular levels, enhancing expression of myelin basic protein and facilitating the growth of cell processes. We have conclusively demonstrated that Sirt2 enhances CG4 oligodendroglial differentiation and report a novel mechanism through which Nkx2.2 represses CG4 oligodendroglial differentiation via Sirt2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669943     DOI: 10.1093/jmcb/mjr009

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  32 in total

Review 1.  How histone deacetylases control myelination.

Authors:  Claire Jacob; Frédéric Lebrun-Julien; Ueli Suter
Journal:  Mol Neurobiol       Date:  2011-08-23       Impact factor: 5.590

Review 2.  Epigenetics in NG2 glia cells.

Authors:  Sarah Moyon; Jialiang Liang; Patrizia Casaccia
Journal:  Brain Res       Date:  2015-06-17       Impact factor: 3.252

3.  Sirt2 epigenetically down-regulates PDGFRα expression and promotes CG4 cell differentiation.

Authors:  Na Fang; Junjun Cheng; Chu Zhang; Keyuan Chen; Chenyu Zhang; Zichao Hu; Ran Bi; Kendra L Furber; Merlin Thangaraj; Adil J Nazarali; Shaoping Ji
Journal:  Cell Cycle       Date:  2019-05-10       Impact factor: 4.534

4.  RNA-binding Protein Quaking Stabilizes Sirt2 mRNA during Oligodendroglial Differentiation.

Authors:  Merlin P Thangaraj; Kendra L Furber; Jotham K Gan; Shaoping Ji; Larhonda Sobchishin; J Ronald Doucette; Adil J Nazarali
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

Review 5.  Epigenetic modifications-insight into oligodendrocyte lineage progression, regeneration, and disease.

Authors:  Alexander Gregath; Qing Richard Lu
Journal:  FEBS Lett       Date:  2018-02-22       Impact factor: 4.124

6.  Does Sirt2 Regulate Cholesterol Biosynthesis During Oligodendroglial Differentiation In Vitro and In Vivo?

Authors:  Merlin P Thangaraj; Kendra L Furber; LaRhonda Sobchishin; Shaoping Ji; J Ronald Doucette; Adil J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2017-08-21       Impact factor: 5.046

7.  Mammalian SIRT2 inhibits keratin 19 expression and is a tumor suppressor in skin.

Authors:  Mei Ming; Lei Qiang; Baozhong Zhao; Yu-Ying He
Journal:  Exp Dermatol       Date:  2014-03       Impact factor: 3.960

8.  Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging.

Authors:  Liana R Stein; Shin-ichiro Imai
Journal:  EMBO J       Date:  2014-05-08       Impact factor: 11.598

9.  Histone deacetylase expression in white matter oligodendrocytes after stroke.

Authors:  Haifa Kassis; Michael Chopp; Xian Shuang Liu; Amjad Shehadah; Cynthia Roberts; Zheng Gang Zhang
Journal:  Neurochem Int       Date:  2014-03-19       Impact factor: 3.921

10.  The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models.

Authors:  Vanita Chopra; Luisa Quinti; Jinho Kim; Lorraine Vollor; K Lakshmi Narayanan; Christina Edgerly; Patricia M Cipicchio; Molly A Lauver; Soo Hyuk Choi; Richard B Silverman; Robert J Ferrante; Steven Hersch; Aleksey G Kazantsev
Journal:  Cell Rep       Date:  2012-11-29       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.